All Stories

  1. Egyptian guidelines for the treatment of Rheumatoid Arthritis — 2022 update

    Article • Egyptian Rheumatology and Rehabilitation, October 2022, Springer Science + Business Media

    Dr Mervat Eissa

  2. How to optimize recruitment strategies of patients with rheumatic and musculoskeletal diseases for online surveys: experience from an international study

    Article • Rheumatology International, September 2022, Springer Science + Business Media

    Dr Mervat Eissa

  3. Osteoporosis clinical practice guideline: romosozumab for treating severe osteoporosis – an update by the Egyptian Academy of Bone Health

    Article • Egyptian Rheumatology and Rehabilitation, September 2022, Springer Science + Business Media

    Dr Mervat Eissa

  4. Egyptian evidence-based consensus on clinical practice recommendations for the management of lupus nephritis

    Article • Egyptian Rheumatology and Rehabilitation, September 2022, Springer Science + Business Media

    Dr Mervat Eissa

  5. Egyptian recommendations for treating to target of lupus nephritis: an evidence-based consensus on clinical practice recommendations for the management of lupus nephritis and pregnancy

    Article • Egyptian Rheumatology and Rehabilitation, August 2022, Springer Science + Business Media

    Dr Mervat Eissa

  6. MicroRNA-199a-5p and Autophagy related gene 5 in Behçet’s Disease: Possible Relation and Association with Disease Severity

    Article • Egyptian Journal of Chemistry, July 2022, Egypts Presidential Specialized Council for Education and Scientific Research

    Dr Mervat Eissa

  7. Egyptian evidence-based consensus on clinical practice recommendations for the management of familial Mediterranean fever

    Article • Egyptian Rheumatology and Rehabilitation, June 2022, Springer Science + Business Media

    Dr Mervat Eissa

  8. Correction: Consensus evidence-based clinical practice recommendations for the management of fibromyalgia

    Article • Egyptian Rheumatology and Rehabilitation, June 2022, Springer Science + Business Media

    Dr Mervat Eissa

  9. Correction: Updated clinical practice treat-to-target guidelines for JIA management: the Egyptian College of Pediatric Rheumatology initiative

    Article • Egyptian Rheumatology and Rehabilitation, June 2022, Springer Science + Business Media

    Dr Mervat Eissa

  10. Egyptian evidence-based consensus on clinical practice guidelines for the diagnosis and treat-to-target management of macrophage activation syndrome in children

    Article • Egyptian Rheumatology and Rehabilitation, June 2022, Springer Science + Business Media

    Dr Mervat Eissa

  11. Correction: Egyptian consensus on treat-to-target approach of gout: evidence-based clinical practice guidelines for the management of gout

    Article • Egyptian Rheumatology and Rehabilitation, June 2022, Springer Science + Business Media

    Dr Mervat Eissa

  12. Psoriatic arthritis treatment to the target: a consensus, evidence-based clinical practice recommendations for the management of psoriatic arthritis and its concomitant clinical manifestations

    Article • Egyptian Rheumatology and Rehabilitation, June 2022, Springer Science + Business Media

    Dr Mervat Eissa

  13. Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries

    Article • The Lancet Rheumatology, March 2022, Elsevier

    Dr Mervat Eissa

  14. Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines

    Article • Rheumatology International, January 2022, Springer Science + Business Media

    Dr Mervat Eissa

  15. Consensus Evidence-Based Clinical Practice Recommendations for the Diagnosis and Treat-To-Target Management of Osteoporosis in Chronic Kidney Disease Stages G4-G5D and Post-transplantation: An Initiative of Egyptian Academy of Bone Health

    Article • Kidney Diseases, January 2022, Karger Publishers

    Dr Mervat Eissa

  16. Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis

    Article • Therapeutic Advances in Musculoskeletal Disease, January 2021, SAGE Publications

    Dr Mervat Eissa

  17. Effect of education on disease activity and functional status in rheumatoid arthritis patients

    Article • The Egyptian Rheumatologist, January 2021, Elsevier

    Dr Mervat Eissa

  18. The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study

    Article • Clinical Rheumatology, September 2020, Springer Science + Business Media

    Dr Mervat Eissa

  19. Impact of the COVID‐19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries

    Article • International Journal of Rheumatic Diseases, September 2020, Wiley

    Dr Mervat Eissa

  20. Prevalence and characteristics of neuropsychiatric involvement in an Egyptian cohort of systemic lupus erythematosus patients: a single-center retrospective cohort

    Article • Egyptian Rheumatology and Rehabilitation, August 2020, Springer Science + Business Media

    Dr Mervat Eissa

  21. Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis

    Article • Rheumatology, August 2020, Oxford University Press (OUP)

    Dr Mervat Eissa

  22. Influence of glutathione S transferase A1 gene polymorphism (-69C > T, rs3957356) on intravenous cyclophosphamide efficacy and side effects: a case-control study in Egyptian patients with lupus nephritis

    Article • Clinical Rheumatology, July 2020, Springer Science + Business Media

    Dr Mervat Eissa

  23. Probiotics as a prophylaxis to prevent oral candidiasis in patients with Sjogren's syndrome: a double-blinded, placebo-controlled, randomized trial

    Article • Rheumatology International, March 2020, Springer Science + Business Media

    Dr Mervat Eissa

  24. Assessment of superficial and deep retinal vessel density in systemic lupus erythematosus patients using optical coherence tomography angiography

    Article • Graefe s Archive for Clinical and Experimental Ophthalmology, March 2020, Springer Science + Business Media

    Dr Mervat Eissa

  25. Combined gemfibrozil (peroxisome proliferator-activated receptor alpha agonist) with reduced steroid dose gives a similar management picture as the full steroid dose in a rat adjuvant-induced arthritis model

    Article • Modern Rheumatology, September 2018, Oxford University Press (OUP)

    Dr Mervat Eissa, Hend Ashour

  26. THU0604 Juvenile inflammatory arthritis: the development and validation of an illustrated questionnaire to measure children’s motivation

    Article • June 2018, BMJ

    Dr Mervat Eissa

  27. Disability in rheumatoid arthritis patients

    Article • Reumatología Clínica, May 2018, Elsevier

    Dr Mervat Eissa, Prof Marwa Ahmed Hany Hammad

  28. 110 Role of anti-CCP, hsCRP and musculoskeletal ultrasound in detection of disease activity and severity of juvenile idiopathic arthritis

    Article • Rheumatology, April 2018, Oxford University Press (OUP)

    Dr Mervat Eissa

  29. Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center

    Article • Lupus, February 2018, SAGE Publications

    Khaled Elhadidi, Dr Mervat Eissa, Dr Basma M Medhat

  30. Juvenile inflammatory arthritis: Development and validation of an illustrated questionnaire for measurement of children’s and adolescents’ motivation

    Article • Rheumatology and Orthopedic Medicine, January 2018, Open Access Text Pvt, Ltd.

    Dr Mervat Eissa

  31. Comparison between different disease activity scores in rheumatoid arthritis: an Egyptian multicenter study

    Article • Clinical Rheumatology, May 2017, Springer Science + Business Media

    Dr Mervat Eissa, Prof Marwa Ahmed Hany Hammad

  32. 321. CLINICAL CHARACTERISTICS OF SYSTEMIC LUPUS ERYTHREMATOSUS IN AN EGYPTIAN POPULATION: A DESCRIPTIVE RETROSPECTIVE CASE SERIES

    Article • Rheumatology, April 2017, Oxford University Press (OUP)

    Dr Mervat Eissa

  33. 187. COMPARISON BETWEEN DIFFERENT DISEASE ACTIVITY SCORES IN RHEUMATOID ARTHRITIS: AN EGYPTIAN MULTICENTER STUDY

    Article • Rheumatology, April 2017, Oxford University Press (OUP)

    Dr Mervat Eissa

  34. Possible risk factors associated with greater damage in systemic lupus erythematosus patients: an Egyptian multicenter study

    Article • Lupus, August 2016, SAGE Publications

    Dr Mervat Eissa, Prof Marwa Ahmed Hany Hammad

  35. AB0367 Prevalence and Impact of Hepatitis C Virus Infection on Egyptian Rheumatoid Arthritis Patients

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    Dr Mervat Eissa

  36. E53. Serum Sclerostin Level Among Egyptian Rheumatoid Arthritis Patients: Relation to Bone Mineral Density, Disease Activity and Radiological Grading

    Article • April 2015, Oxford University Press (OUP)

    Dr Mervat Eissa

  37. E12. Coexistent Ankylosing Spondylitis and Systemic Lupus Erythematosus

    Article • April 2015, Oxford University Press (OUP)

    Dr Mervat Eissa

  38. AB0270 Serum Sclerostin Level among Egyptian Rheumatoid Arthritis Patients: Relation to Bone Mineral Density, Disease Activity and Radiological Grading

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    Dr Mervat Eissa

  39. Characteristics of rheumatoid arthritis patients with concomitant hepatitis C virus infection

    Article • The Egyptian Rheumatologist, July 2011, Elsevier

    Dr Mervat Eissa